Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Atricure (ATRC – Research Report), Charles River Labs (CRL – Research Report) and Shockwave Medical (SWAV – Research Report).
Atricure (ATRC)
Piper Sandler analyst Matthew O’Brien reiterated a Buy rating on Atricure today and set a price target of $65.00. The company’s shares closed last Thursday at $34.21, close to its 52-week low of $30.74.
According to TipRanks.com, O’Brien is a 5-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Atricure with a $57.50 average price target, a 74.6% upside from current levels. In a report released today, JMP Securities also reiterated a Buy rating on the stock with a $60.00 price target.
See the top stocks recommended by analysts >>
Charles River Labs (CRL)
Morgan Stanley analyst Tejas Savant maintained a Hold rating on Charles River Labs today and set a price target of $235.00. The company’s shares closed last Thursday at $245.40, close to its 52-week high of $257.18.
According to TipRanks.com, Savant is ranked #8104 out of 8732 analysts.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Charles River Labs with a $261.44 average price target, a 8.0% upside from current levels. In a report released yesterday, Guggenheim also downgraded the stock to Hold.
Shockwave Medical (SWAV)
Piper Sandler analyst Adam Maeder reiterated a Buy rating on Shockwave Medical today and set a price target of $290.00. The company’s shares closed last Thursday at $236.32.
According to TipRanks.com, Maeder is a 5-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Shockwave Medical with a $243.00 average price target, implying a 4.8% upside from current levels. In a report released today, Morgan Stanley also maintained a Buy rating on the stock with a $285.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ATRC:
